Quality of Life Improves with Alemtuzumab Over 6 Years in Relapsing-Remitting Multiple Sclerosis Patients with or without Autoimmune Thyroid Adverse Events: Post Hoc Analysis of the CARE-MS Studies

Autor: Bertolotto, Antonio, Arroyo, Rafael, Celius, Elisabeth Gulowsen, Comi, Giancarlo, Havrdova, Eva, Honeycutt, William David, Hunter, Samuel F., Izquierdo, Guillermo, Kornek, Barbara, Miller, Tamara, Mitsikostas, Dimos-Dimitrios, Singer, Barry A., Ziemssen, Tjalf, Chung, Luke, Daizadeh, Nadia, Afsar, Salman, Hashemi, Lobat, Senior, Peter

Publikováno v: Bertolotto, Antonio Arroyo, Rafael Celius, Elisabeth Gulowsen Comi, Giancarlo Havrdova, Eva Honeycutt, William David Hunter, Samuel F. Izquierdo, Guillermo Kornek, Barbara Miller, Tamara Mitsikostas, Dimos-Dimitrios Singer, Barry A. Ziemssen, Tjalf Chung, Luke Daizadeh, Nadia Afsar, Salman Hashemi, Lobat Senior, Peter . Quality of Life Improves with Alemtuzumab Over 6 Years in Relapsing-Remitting Multiple Sclerosis Patients with or without Autoimmune Thyroid Adverse Events: Post Hoc Analysis of the CARE-MS Studies. Neurology and Therapy. 2020, 9(2), 443-457
Neurology and Therapy

Externí odkaz: http://hdl.handle.net/10852/84987
https://www.duo.uio.no/bitstream/handle/10852/84987/2/Quality%2Bof%2BLife%2BImproves%2Bwith%2BAlemtuzumab%2BOver.pdf

Quality of Life Improves with Alemtuzumab Over 6 Years in Relapsing-Remitting Multiple Sclerosis Patients with or without Autoimmune Thyroid Adverse Events: Post Hoc Analysis of the CARE-MS Studies.

Autor: Bertolotto A; SCDO Neurologia-CRESM (Centro Riferimento Regionale Sclerosi Multipla), University Hospital San Luigi Gonzaga, Orbassano, Turin, Italy. antonio.bertolotto@gmail.com., Arroyo R; Hospital Universitario Quirónsalud Madrid, Madrid, Spain., Celius EG; Oslo University Hospital Ullevål and Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Comi G; University Vita-Salute San Raffaele, Milan, Italy., Havrdova EK; First Medical Faculty, Charles University, Prague, Czech Republic., Honeycutt WD; Neurology Associates, Maitland, FL, USA., Hunter SF; Advanced Neurosciences Institute, Franklin, TN, USA., Izquierdo G; Vithas Nisa Hospital, Seville, Spain., Kornek B; Medical Neuroscience Cluster, Medical University of Vienna, Vienna, Austria., Miller T; Advanced Neurology of Colorado, Fort Collins, CO, USA., Mitsikostas DD; 1st Neurology Department, Aeginition Hospital, National and Kapodistrian University of Athens, Athens, Greece., Singer BA; MS Center for Innovations in Care, Missouri Baptist Medical Center, St Louis, MO, USA., Ziemssen T; Center of Clinical Neuroscience, Carl Gustav Carus University Hospital, Dresden, Germany., Chung L; Sanofi, Cambridge, MA, USA., Daizadeh N; Sanofi, Cambridge, MA, USA., Afsar S; Sanofi, Cambridge, MA, USA., Hashemi L; Sanofi, Cambridge, MA, USA., Senior P; University of Alberta, Edmonton, AB, Canada.

Publikováno v: Neurology and therapy [Neurol Ther] 2020 Dec; Vol. 9 (2), pp. 443-457. Date of Electronic Publication: 2020 May 14.